miR-200C-3p靶向调控ZEB2抑制前列腺癌细胞增殖和迁移的实验研究 |
| |
引用本文: | 李虎,朱永士,王宁宁,郭绍永,陈志军. miR-200C-3p靶向调控ZEB2抑制前列腺癌细胞增殖和迁移的实验研究[J]. 中华全科医学, 2021, 19(11): 1846-1850. DOI: 10.16766/j.cnki.issn.1674-4152.002182 |
| |
作者姓名: | 李虎 朱永士 王宁宁 郭绍永 陈志军 |
| |
作者单位: | 1.安徽皖北煤电集团总医院泌尿外科,安徽 宿州 234000 |
| |
基金项目: | 安徽省高校自然科学研究项目KJ2019A0355 |
| |
摘 要: | 目的 前列腺癌的进展与多种因素有关,本研究旨在探索miR-200C-3p对前列腺癌细胞系的影响,并分析miR-200C-3p与ZEB2的潜在机制。 方法 通过qRT-PCR检测miR-200C-3p在前列腺癌细胞系PC-3、DU145、前列腺上皮细胞RWPE-1的表达量。DU145转染miR-200C-3p后,通过CCK-8、划痕修复实验以及Transwell实验探究增殖与迁移能力。沉默ZEB2后分析DU145增殖和迁移能力的变化,采用双荧光素酶报告法蛋白免疫印迹实验测定miR-200C-3p与E盒结合锌指蛋白2(zinc finger E-box binding homeobox 2,ZEB2)的潜在关系。 结果 qRT-PCR结果显示RWPE-1中miR-200C-3p表达量是DU145的2.5倍左右。DU145转染miR-200C-3p mimics后CCK-8实验组的增殖能力明显弱于对照组,划痕修复实验实验组[(20.33±1.45)%]与对照组[(46.67±2.40)%]相比愈合能力明显减弱(P < 0.001),Transwell实验结果表明实验组(114.30±5.21)与对照组(212.00±6.49)相比迁移能力显著下降(P < 0.001)。沉默ZEB2可抑制DU145细胞的增殖和迁移能力(P < 0.05),双荧光素酶报告和蛋白免疫印迹实验证实miR-200C-3p在DU145中过表达降低了ZEB2的蛋白表达(P < 0.05)。 结论 miR-200C-3p通过介导ZEB2抑制DU145的增殖和迁移。
|
关 键 词: | 前列腺癌 miR-200C-3p E盒结合锌指蛋白2 增殖 迁移 |
收稿时间: | 2021-02-11 |
miR-200C-3p inhibit the proliferation and migration of prostate cancer cells via targeting ZEB2 |
| |
Affiliation: | Department of Urology, Anhui Wanbei Coal and Electricity Group General Hospital, Suzhou, Anhui 234000, China |
| |
Abstract: | Objective To explore the effect of miR-200C-3p on prostate cancer cell lines and analyze the potential mechanisms of miR-200C-3p and Zinc finger E-box-binding homeobox 2 (ZEB2). Methods The expression of miR-200C-3p in prostate cancer cell lines PC-3, DU145, and prostate epithelial cells RWPE-1 was detected by qRT-PCR. After DU145 was transfected with miR-200C-3p, the proliferation and migration ability were determined by CCK-8, scratch repair test and Transwell test. After silencing ZEB2, the proliferation and migration ability of DU145 was analyzed, and the potential relationship between miR-200C-3p and ZEB2 was determined by double-luciferase reporter and western blotting. Results The results of qRT-PCR showed that the expression of miR-200C-3p in RWPE-1 was about 2.5 times that of DU145. After DU145 was transfected with miR-200C-3p mimics, the proliferation ability of experimental group was significantly weaker than that of the control group. The healing ability of the experimental group (20.33±1.45) % was significantly lower than that of the control group (46.67±2.40) % (P < 0.001), and the migration ability of the experimental group (114.30±5.21) was significantly lower than that of the control group (212.00±6.49, P < 0.001). Silencing ZEB2 inhibited the proliferation and migration ability of DU145 cells (P < 0.05). The dual luciferase report and western blot experiments confirmed that the overexpression of miR-200C-3p in DU145 reduced the protein expression of ZEB2 (P < 0.05). Conclusion miR-200C-3p inhibits the proliferation and migration of DU145 by mediating ZEB2. |
| |
Keywords: | |
|
| 点击此处可从《中华全科医学》浏览原始摘要信息 |
|
点击此处可从《中华全科医学》下载免费的PDF全文 |
|